MicrobiologybioRxivPreprint
Efficacy of the oral nucleoside prodrug GS-5245 (Obeldesivir) against SARS-CoV-2 and coronaviruses with pandemic potential
D. R. Martinez, F. Moreira, M. R. Zweigart…·T. P. Sheahan
This study evaluates the antiviral efficacy of GS-5245 against multiple SARS-CoV-2 variants and other coronaviruses, showing broad in vitro activity and protective effects in animal models.
DOI 10.1101/2023.06.27.546784